Debiopharm Innovation Fund’s portfolio company BC Platforms to create a Health Data Discovery Platform for the UK’s National Biobank Network

Debiopharm Innovation Fund’s portfolio company BC Platforms, a world leader in genomic data management and analytics, announced this morning it has entered into a research collaboration with the UK’s national biobanking platform in order to enable clinical and genetic data to be integrated, supported by the recently established Health Data Research UK; a research institute set up to help improve lives through better use of data.

Read their full press release here.